News - Amgen, secukinumab

Filter

Current filters:

Amgensecukinumab

Popular Filters

Novartis' secukinumab demonstrates superiority to rival Enbrel in psoriasis study

08-07-2013

Swiss drug major Novartis (NOVN: VX) has announced results from a Phase III psoriasis study which showed…

AbbVieAmgenDermatologicalsEnbrelHumiraJanssen BiotechNovartisPharmaceuticalsecukinumabStelara Injectiontofacitinib

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top